Autore
ANGIOLO GADDUCCI
Unimap Dati autore
- Professore Associato presso Dipartimento di Medicina della Procreazione e dell'Eta' Evolutiva
- Membro della Facolta' di Medicina e Chirurgia
- Settore scientifico disciplinare MED/40 GINECOLOGIA E OSTETRICIA
- In servizio
Prodotti
- Abstract
- Glomerular filtration rate can be predicted from plasma creatinine and body composition analysis in ovarian cancer patients 2001
- Standard-dose chemotherapy in gynecologic oncologic elderly patients over 70 years 2001
- The prognostic relevance of histological type in uterine sarcomas: a CTF multivariate analysis of 249 cases 2001
- Melanoma 2002
- Weekly paclitaxel as consolidation treatment in patients with advanced ovariac cancer who attained patological microscopic partial remission (MPR): An Italian phase II multicenter study (AFTER-6 protocol 2) 2002
- Computed tomography and CA 125 in the follow-up of ovarian cancer: a preliminary experience 2004
- P53 e bax nei carcinomi sierosi avanzati: esperienza monoistituzionale su 41 casi 2004
- Serum CA 125 half-life duerin paclitaxel/platinum-based chemotherapy in patients with advanced ovarian caner: relationship with response to chemotherapy and survival. 2004
- Sex-steroid hormones, gonadotropin and ovarian carcinogenesis: a review of epidemiological and experimental data 2004
- Final results of After-6 protocol 1: A phase III trial of observation versus 6 courses of paclitaxel (Pac) in advanced ovarian cancer patients in complete response (CR) after platinum-paclitaxel chemotherapy (CT). 2007
- A phase II combination study of bortezomib with pegylated-liposomal doxorubicin in patients with ovarian cancer failing platinum containing regimens 2008
- Articoli
- Adjuvant treatment of stage I.-II malignant mixed mesodermal tumors (MMT) of the uterus: a multicenter CTF study 1996
- Carcinoma della tuba di Falloppio.Aspetti diagnostici, prognostici e terapeutici 1996
- Current status of preoperative and adjuvant irradiation in endometrial cancer:a CTF analysis in West Europe 1996
- Differential diagnosis of adnexal masses with transvaginal sonography, color flow imaging and serum CA 125 assay in pre- and post-menopausal women 1996
- Endometrial stromal sarcoma: Analysis of treatment failures and survival 1996
- Fattori prognostici e trattamento dei carcinosarcomi dell'utero 1996
- Gamma-glutamyl traspeptidase activity in human ovarian carcinoma 1996
- High-dose versus low-dose cisplatin in combination with cyclophoshamide and epidoxorubicin in suboptimal ovarian cancer: a randomized study of the Gruppo Oncologico Nord- Ovest 1996
- Minimization of cisplatin nephrotoxicity in high-risk patients 1996
- Preoperative evaluation of D-dimer and CA 125 levels in differentiating benign from malignant ovarian masses 1996
- Preoperative serum antibodies against the p53 protein in patients with ovarian and endometrial cancer 1996
- Prevention of cis-platinum nephrotoxicity in high-risk patient 1996
- Prognostic role of immunosuppressive acidic protein in advanced ovarian cancer 1996
- Prothrombin fragment F1+2 and thrombin-antithrombin III complex (TAT) plasma levels in patients with gynecological cancer 1996
- Serum CA125 assay in the early diagnosis of recurrent epithelial ovarian cancer:a CTF study 1996
- Serum levels of soluble receptors for tumor necrosis factor (p55 and p75 sTNFr) in endometrial cancer 1996
- Serum levels of tumor necrosis factor (p55 and p75 sTNFr) in patients with cervival cancer 1996
- The relationship between postoperative decline of serum CA 125 levels and size of residual disease after initial surgery in patients with advanced ovarian cancer: A CTF study 1996
- Tumeurs feminisantes de' l'ovaire 1996
- Twelve-year follow-up of a randomized trial comparing cisplatin and ciclophosphamide with cisplatin, doxorubicin and ciclophosphamide in patients with advanced epithelial ovarian cancer 1996
- Uterine leiomyosarcoma: Analysis of treatment failures and survival 1996
- il follow-up delle neoplasie ginecologiche 1996
- Anlysis of failures in patients with stage I ovarian cancer: an italian multicenter study 1997
- Carcinosarcoma of the uterus : a clinicopathological multicenter CTF study 1997
- Hormone replacement therapy and gynecological cancer 1997
- I tumori border-line dell'ovaio 1997
- Il carcinoma invasivo della vagina 1997
- Il carcinoma ovarico in I stadio : variabili prognostiche e problematiche terapeutiche 1997
- Intraperitoneal carboplatin with or without interferon-alpha in advanced ovarian cancer patients with minimal residual disease at second-look: A prospective randomized trial of 111 patients . GONO. gruppo Oncologico Nord Ovest 1997
- Ovarian cancer in elderly women 1997
- Platinum compounds and paclitaxel in advanced epithelial ovarian cancer 1997
- Preoperative D-dimer plasma assay is not a predictor of clinical outcome for patients with advanced ovarian cancer 1997
- Serum CA125 assay at the time of relapse as no prognostic relevance in patients undergoing chemotherapy for recurrent ovarian cancer: a multicenter italian study 1997
- Serum assay of soluble CD 44 standard (sCD44-st), CD 44 splice variant v5 (sCD 44-v5), and CD 44 splice variant v6 (sCD 44-v6) in patients with epithelial ovarian cancer 1997
- Steroid hormones in endometrial and breast cancer.Review. 1997
- p53 alterations are predictive of chemoresistence and aggressiveness in ovarian carcinoma: a molecular and immunohistochemical study 1997
- Alterazioni del gene p53 e carcinoma ovarico 1998
- An analysis of approaches to the management of endometrial cancer in North America : a CTF study 1998
- Analysis of failures after negative second-look in patients with advanced ovarian cancer: an italian multicenter study 1998
- Endometrial cancer:Analysis of treatment modality in Italy 1998
- Evaluation of FHIT gene alterations in ovarian cancer 1998
- Expression and secretion of inhibin and activin in normal and neoplastic uterine tissues.High levels of serum activin A in women with endometrial and cervical carcinoma 1998
- Il follow-up dei tumori maligni epiteliali dell'ovaio. possibilità e limiti in tema di follow-up in oncologia ginecologica 1998
- Serum anti-p53 antibodies in the follow-up op patients with advanced ovarian carcinoma 1998
- Serum macrophage colony-stimulating factor (M-CSF) levels in patients with epithelial ovarian cancer 1998
- Survival after intestinal obstruction in patients with fatal ovarian cancer: Analysis of prognostic variables 1998
- The serum assay of soluble CD44 standard (sCD44-st), CD44 splice variant 5 (sCD44-v5), and CD44 splice variant 6 (sCD44-v6) in patients with cervical cancer 1998
- Assestment of the prognostic relevance of serum anti-p53 antibodies in epithelial ovarian cancer 1999
- Benign ovarian fibroma associated with free peritoneal fluid and elevated serum CA 125 levels 1999
- Combination of cisplatin, epirubicin, and cyclophosphamide (PEC regimen) in advanced or recurrent endometrial cancer: a retrospective clinical study 1999
- Endocrine therapy for gynecological cancer 1999
- La gravidanza dopo terapia antitumorale 1999
- Neoplasie ginecologiche e gravidanza. 1999
- Preoperative serum E-cadherin assay in patients with ovarian carcinoma 1999
- Serum preoperative vascular endothelial growth factor (VEGF) in epithelial ovarian cancer: relationship wiyh prognostic variables and clinical outcome 1999
- Significato biologico e clinico delle metalloproteinasi nel carcinoma dell'ovaio e della cervice uterina 1999
- Up date in the management of advanced ovarian carcinoma 1999
- An intensive follow-up does not chance survival of patients with clinical stage I endometrial cancer 2000
- Complete salvage surgical cytoreduction improves further survival of patients with late recurrent ovarian cancer 2000
- Fattori prognostici e terapia adiuvante dei sarcomi dell'utero. 2000
- Intraperitoneal versus intravenous cisplatin in combination with intravenous cyclophosphamide and epidoxorubicin in optimally cytoreced advanced epithelial ovarian cancer: a randomized trial of the Gruppo Oncologico Nord-Ovest 2000
- La terapia dei linfonodi positivi nel carcinoma endometriale 2000
- Ovarian cancer: optimal chemotherapy in relapsed disease 2000
- Patterns of recurrence in patients with squamous cell carcinoma of the vulva. A multicenter CTF study 2000
- Serum markers as prognostic factors in epithelial ovarian cancer: an overview 2000
- Surgical cytoreduction during second-look laparotomy in patients with advanced ovarian cancer 2000
- Terapia adiuvante e carcinoma ovarico 2000
- ovarian cancre:optimal chemotherapy in relapsed disease 2000
- p53 status is neither a predictive nor a prognostic variable in patients with advanced ovarian cancer treated with a paclitaxel-based regimen 2000
- Advanced ovarian cancer in the elderly:results of consecutive trials with cisplatin-based chemotherapy 2001
- Afjuvant chemotherapy in early stage uterine sarcomas: an open question 2001
- Analysis of treatment failures and survival of patients with fallopian tube carcinoma: a cooperation Task Force (CTF) study 2001
- Clinical behavior of 203 stage II endometrial cancer cases: the impact of primary surgical approach and of adjuvant radiation therapy 2001
- Controversial issues in climacterial medicine.II.Hormone replacement therapy and cancer 2001
- Il carcinoma della tuba di Falloppio: problematiche diagnostiche e terapeutiche 2001
- La terapia del carcinoma endometriale avanzato 2001
- Malnutrition and cachexia in ovarian cancer patients:pathophysiology ana management 2001
- Neoadjuvant chemotherapy and concurrent chemoradiation in the treatment of cervical cancer 2001
- Second-line treatment and consolidation therapies in advanced ovarian cancer 2001
- The clinical relevance of serum CYFRA 21-1 assay in patients with ovarian cancer 2001
- Treatment options in patientgs with recurrent ovarian cancer. 2001
- controversial issues in climacteric medicine II. Hormone replacement therapy and cancer: International Menopause Society Expert Workshop. 9-12 June 2001, Opera del duomo, Pisa, Italy 2001
- terapia ormonale sostitutiva dopo tumori non ginecologici in età fertile: tumori della tiroide, melanomi, meningiomi, tumori emopoietici e tumori del colon 2001
- Analysis of the evolution in the manageent of endometrial cancer in Italy: a CTF study. 2002
- Current management of fallopian tube carcinoma 2002
- Diagnosi e terapia delle recidive del carcinoma della vulva. Patologia benigna e carcinoma della vulva 2002
- Molecular mechanism of apoptosis and chemosensitivity to platinum and paclitaxel in ovarian cancer: biological data and clinical implications 2002
- The prognostic relevance of histological type in uterine sarcomas: a Cooperation Task Force (CTF) multivariate analysis of 249 cases 2002
- gynecolagical malignancies in elderly patients: is age 70 a limit to standard-dose chemotherapy?An Italian multicentric study 2002
- reply 2002
- Chemotherapy with epirubicin and paclitaxel for breast cancer during pregnancy: Case-report and review of the literature 2003
- Chemotherapy with epirubicin and paclitaxel for breast cancer during pregnancy: Case-report and review of the literature 2003
- Factors influencing survival in endometrial cancer relapsing patients: a Cooperation Task Force (CTF) study 2003
- First-line chemotherapy with epidoxorubicin, paclitaxel, and carboplatin for the treatment of advanced epithelial ovarian cancer patients 2003
- Human telomerase reverse transcriptase mRNA expression assessed by real-time reverse transcription polymersae chain reaction predicts chemosensitivity in patients with ovarian carcinoma 2003
- Intratumoral microvessel density, response to chemotherapy and clinical outcome of patients with advanced ovarian carcinoma. 2003
- Is pretreatment hemoglobin level a predictor of complete response to salvage chemotherapy for recurrent platinum-pretreated ovarian carcinoma? 2003
- Is reduction in size pathognomonic of functional ovarian cysts? 2003
- Markers sierologici nelle tumefazioni ovariche 2003
- Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-VAR-2.2 trial 2003
- Phase III multicenter randomized trial of amifostine as cytoprotectant in first-line chemoterapy in ovarian cancer patients. 2003
- Prognosi e qualità di vita delle pazienti trattate per neolasia maligna dell'ovaio in età fertile. 2003
- Renal impairment in patients with ovarian cancer. 2003
- The clinical outcome of patients with stage Ia1 and Ia2 squamous cell carcinoma of the uterine cervix : a Cooperation Task Force (CTF) study 2003
- The management of malignant nondysgerminomatous ovarian germ cell tumors. 2003
- The role of the French-Italian glossary of complications in the outcome evaluation of cervical treatment: an Italian multicentric study 2003
- Treatment planning in endometrial cancer 2003
- Valor clinico del analisis de marcadores sericos en el cancer ginecologico: experencial italiana y revision des los estudios publicados 2003
- Vascular endothelial growth factor (VEGF) expression in primary tumors and peritoneal metastases from patients with advanced ovarian cancer 2003
- An analysis of different approaches to ovarian cysts in Italy 2004
- Chemioterapia nel carcinoma ovarico avanzato. 2004
- Combined treatment with chemotherapy and radiotherapy in high-risk FIGO stage III-IV endometrial cancer patients 2004
- Hormone repalcement therapy in cancer survivors 2004
- Nuove terapie di ricerca e studi clinici controllati nella terapia del carcinoma ovarico avanzato 2004
- Reproductive variables, fertility drugs and epithelial ovarian tumor risk 2004
- Serum tumor markers in the management of ovarian, endometrial and cervical cancer 2004
- Sex steroid hormones, gonadotropin and ovarian carcinogenesis: a review of epidemiological and experimental data 2004
- The predictive and prognostic value of serum CA 125 half-life during paclitaxel/platinum-based chemotherapy in patients with advanced ovarian carcinoma. 2004
- Use of estrogen antagonists and aromatase inhibitors in breast cancer and hormonally sensitive tumors of the uterine body 2004
- Breast cancer and sex steroids: critical review of epidemiological, experimental and clinical investigations on etiopathogenesis, chemoprevention and endocrine treatment of breast cancer. 2005
- Consolidation and maintenance treatments for patients with advanced epithelial ovarian cancer in complete response after first-line chemotherapy: a review of the literature. 2005
- Le masse pelviche in perimenopausa e postmenopausa 2005
- Neutropenic enterocolitis in an advanced epithelial ovarian cancer patient treated with paclitaxelplatinum-based chemotherapy: a case report and review of the literature. 2005
- Polycystic ovary syndrome and gynecological cancers: is there a link? 2005
- Polycystic ovary syndrome and gynecological cancers: is there a link? 2005
- Pre-chemotherapy hemoglobin levels and survival in patients with advanced epithelial ovarian cancer who received a first-line taxane/platinum-based regimen: results of a multicenter retrospective Italian study. 2005
- neutropenic enterocolitis in an advanced ovarian cancer patient treated with paclitaxel/platinum-based chemotherapy: a case report and review of the literature 2005
- relationship between interval time interval from primary surgery to the start of taxane-plus platinum-based chemotherapy and clinical outcome of patients with advanced eoithelial ovarian cancer: results of a Multicenter Retrospective Italian Study 2005
- Evolving role of serum biomarkers in the management of ovarian cancer 2006
- Intratumoral microvessel density in advanced epithelial ovarian cancer and its use as a prognostic variable 2006
- Management of borderline ovarian tumors: Results of an Italian multicenter study. 2006
- Old and new perspectives in the management of high-risk, locally advanced or recurrent, and metastatic vulvar cancer 2006
- Old and new perspectives in the pharmacological treatment of advanced or recurrent endometrial cancer: Hormonal therapy, chemotherapy and molecularly targeted therapies 2006
- P53 gene status in patients with advanced serous epithelial ovarian cancer in relation to response to paclitaxel-plus platinum-based chemotherapy and long-term clinical outcome. 2006
- Preoperative serum vascular endothelial growth factor as a prognostic parameter in ovarian cancer 2006
- Problematiche, innovazioni e prospettive di ricerca clinica nelle neoplasie ginecologiche 2006
- Tumore dell’ ovaio in età fertile: non tutto è perduto. 2006
- Biochemical prognostic factors and risk of relapses in patients with cervical cancer 2007
- Brain Recurrences in patients with ovarian cancer: report of 12 cases and review of the literature 2007
- Carcinoma della mammella in gravidanza e gravidanza dopo carcinoma della mammella 2007
- Could follow-up different modalities play a role in asymptomatic cervical cancer relapses diagnosis? An Italian multicenter retrospective analysis 2007
- Follow-up strategies in gynecological oncology: searching appropriateness 2007
- Le integrazioni terapeutiche nel carcinoma cervicale avanzato 2007
- Novel targeted therapies in epithelial ovarian cancer: from basic research to the clinic 2007
- Ovarian function and childbearing issues in breast cancer survivors 2007
- Ovarian metastases in early-stage cervical cancer (IA2-IIA): a multicenter retrospective study of 1965 patients (a Cooperative Task Force study). 2007
- Patologia benigna della mammella: significato clinico, rischio oncologico e trattamento 2007
- Prospettive di ricerca clinica nella terapia del carcinoma endometriale. 2007
- Results of the 2006 Innsbruck International Consensus Conference on intraperitoneal chemotherapy in patients with ovarian cancer. 2007
- Surveillance procedures for patients treated for epithelial ovarian cancer: a review of the literature 2007
- Analysis of the pattern of hypersensitivity reactions in patients receiving carboplatin retreatment for recurrent ovarian cancer 2008
- Componente progestinici nella terapia ormonale sostitutiva e rischio di carcinoma mammario 2008
- Controversie e prospettive di ricerca clinica nel trattamento del carcinoma ovarico 2008
- Correlation of recurrence rates and times with posttreatment human papillomavirus status in patients treated with loop electrosurgical excision procedure conization for cervical squamous intraepithelial lesions 2008
- Extra-nuclear signaling of progesterone receptor to breast cancer cell movement and invasion through the actin cytoskeleton. 2008
- Intraperitoneal chemotherapy in the management of patients with advanced epithelial ovarian cancer: a critical review of the literature 2008
- Molecular target therapies in endometrial cancer: from the basic research to the clinic. 2008
- Qualitè de vie et symptomes de la menopause chez les survivantes du cancer du sein 2008
- The management of patients with uterine sarcoma: a debated clinical challenge. 2008
- The serum assay of tumour markers in the prognostic evaluation, treatment monitoring and follow-up of patients with cervical cancer: a review of the literature. 2008
- Are surveillance procedures of clinical benefit for patients treated for ovarian cancer?: A retrospective Italian multicentric study 2009
- Clinical Outcome of Tailored Adjuvant Postoperative Chemoradiotherapy in IB FIGO Stage Cervical Cancer 2009
- Dose individualization can minimize nephrotoxicity due to carboplatin therapy in patients with ovarian cancer. 2009
- Lymph-vascular space involvement and outer one-third myometrial invasion are strong predictors of distant haematogeneous failures in patients with stage I-II endometrioid-type endometrial cancer 2009
- Phase III Trial of Observation Versus Six Courses of Paclitaxel in Patients With Advanced Epithelial Ovarian Cancer in Complete Response After Six Courses of Paclitaxel/Platinum-Based Chemotherapy: Final Results of the After-6 Protocol 1. 2009
- Progestagen component in combined hormone replacement therapy in postmenopausal women and breast cancer risk: a debated clinical issue. 2009
- Prospettive di ricerca clinica nel trattamento del carcinoma della cervice uterina 2009
- Serum and tissue biomarkers as predictive and prognostic variables in epithelial ovarian cancer. 2009
- Surveillance Procedures for Patients With Cervical Carcinoma: A Review of the Literature 2009
- Surveillance of patients after initial treatment of ovarian cancer 2009
- The fertility-sparing treatment in patients with endometrial atypical hyperplasia and early endometrial cancer: A debated therapeutic option. 2009
- The treatment of uterine carcinosarcoma. 2009
- Weekly epirubicin in the treatment of gestational breast cancer (GBC). 2009
- Weekly low-dose paclitaxel as maintenance treatment in patients with advanced ovarian cancer who had microscopic residual disease at second-look surgery after 6 cycles of paclitaxel/platinum-based chemotherapy: results of an open noncomparative phase 2 multicenter Italian study (After-6 Protocol 2) 2009
- Clear cell carcinoma of the endometrium: a biological and clinical enigma 2010
- Clinicopathological variables predictive of clinical outcome in patients with FIGO stage Ib2-IIb cervical cancer treated with cisplatin-based neoadjuvant chemotherapy followed by radical hysterectomy 2010
- Gynaecologic challenging issues in the management of BRCA mutation carriers: oral contraceptives, prophylactic salpingo-oophorectomy and hormone replacement therapy 2010
- Is adjuvant chemotherapy indicated in stage I pure immature ovarian teratoma (IT)? A multicentre Italian trial in ovarian cancer (MITO-9). 2010
- Pattern of failures and clinical outcome of patients with locally advanced cervical cancer treated with a tailored integrated therapeutic approach 2010
- Pretreatment platelet and hemoglobin levels are neither predictive nor prognostic variables for patients with locally advanced cervical cancer treated with neoadjuvant chemotherapy and radical hysterectomy: a retrospective Italian study. 2010
- Surveillance procedures for patients treated for endometrial cancer: a review of the literature 2010
- The clinical outcome of epithelial ovarian cancer patients with apparently isolated lymph node recurrence: a multicenter retrospective Italian study. 2010
- The perioperative management of patients with gynaecological cancer undergoing major surgery: A debated clinical challenge. 2010
- Tissue and serum biomarkers as prognostic variables in endometrioid-type endometrial cancer 2010
- La terapia adiuvante nel carcinoma ovarico iniziale 2011
- Multimodality approach in extra cervical locally advanced cervical cancer: chemoradiation, surgery and intra-operative radiation therapy. A phase II trial. 2011
- Outcome and Risk Factors for Recurrence in Malignant Ovarian Germ Cell Tumors: A MITO-9 Retrospective Study 2011
- Prognostic factors in uterine sarcoma 2011
- Smoking habit, immune suppression, oral contraceptive use, and hormone replacement therapy use and cervical carcinogenesis: a review of the literature 2011
- Strategie e prospettive nella cura dei sarcomi dell'utero 2011
- Surgical and Medical Treatment of Clear Cell Ovarian Cancer: Results From the Multicenter Italian Trials in Ovarian Cancer (MITO) 9 Retrospective Study 2011
- The evolving role of adjuvant therapy in endometrial cancer 2011
- Atti, Riassunti o Comunicazioni
- Chemioterapia di seconda linea con taxolo e dosi cresenti di ifosfamide nel carcinoma ovarico platino-resistente 1996
- Il carcinoma della vulva : le recidive 1996
- Immunoscintigraphy in ovarian cancer 1996
- Serum CA125 in the management of ovarian cancer 1996
- Steroid hormones and endometrial and breast cancer 1996
- Terapia ormonale sostitutiva in pazienti con anamnesi positiva per carcinoma ovarico 1996
- cytokines in ovarian cancer 1996
- La chemioterapia nei sarcomi uterini 1997
- Terapie ormonali ginecologiche e rischio oncogeno 1997
- I sarcomi uterini: Fattori prognostici e indicazioni terapeutiche 1998
- Biological parameters predictive of chemoresistance in ovarian cancer 1999
- Clinical behaviour of 208 stage II endometrial cancer cases 1999
- Neoangiogenesi e carcinoma ovarico: Aspetti prognostici e terapeutici 1999
- Paclitaxel (TAX), carboplatin (CBDCA) and epidoxorubicin (EPIDX) in advanced epithelial ovarian cancer (AEOC) 1999
- Pattern of recurrences in early-stage uterine sarcoma: A retrospective CTF study 1999
- Pattern of recurrences in endometrial cancer: A retrospective CTF study 1999
- Ruolo della radioterapia nel carcinoma endometriale recidivante 1999
- Terapia ormonale sostitutiva e carcinoma ovarico 1999
- Tumor markers of epithelial ovarian cancer: Role in diagnosis and therapy 1999
- p53 status and response to paclitaxel-based chemotherapy in patients with advanced epithelial ovarian cancer 1999
- Correlazione fra mappaggio dei flussi in color-Doppler, velocimetria Doppler e dosaggio di b-HCG plasmatico nella malattia trofoblastica 2000
- Terapia ormonale sostitutiva in pazienti già trattate per carcinoma della mammella 2000
- Il trattamento del carcinoma ovarico. Obiettivi della terapia e fattori prognostici e predittivi 2001
- La chemioterapia del carcinoma ovarico avanzato nelle pazienti anziane 2001
- Leiomioma e leiomiosarcoma: un continuum biologico? Valutazione retrospettiva di 126 casi di leiomiosarcoma 2001
- Terapia ormonale sostitutiva dopo tumori non ginecologici in età fertile: tumori della tiroide, melanomi, meningiomi, tumori emopoietici e tumori del colon 2001
- Alterazioni della coagulazione in ostetricia e ginecologia:problematiche anestesiologiche e chirurgiche 2002
- Randomized phase III trial of observation versus 6 courses of single agent paclitaxel in patients with advanced ovarian cancer who obtained a complete response to platinum-paclitaxel based chemotherapy. An Italian study (AFTER-6 protocol 1) 2002
- epidemiologia del carcinoma ovarico 2002
- trattamento chirirgico palliativo delle recidive di carcinoma ovarico 2002
- tumori border-line dell'ovaio 2002
- carcinoma ovarico e chemioterapia: consolidamento e mantenimento 2005
- Concurrent chemo-radiotherapy using high dose rate intracavitary brachytherapy in uterine cervical cancer 2007
- La terapia adiuvante nel carcinoma dell’ endometrio: quale e quando? 2007
- I tumori dell‘ ovaio. 2008
- Capitoli, Parte,Saggi, Studi, Articoli in libro
- Terapia del carcinoma ovarico. B. Terapia medica - Argomenti di Oncologia 2000
- Farmaci in gravidanza - Gravidanza e allattamento. Gestione ambulatoriale dei principali problemi medici 2000
- Terapia ormonale sostitutiva e neoplasia del tratto genitale - Premenopausa e menopausa 2000
- Carcinoma cervicale, sarcoma uterino e carcinoma ovarico: storia naturale ed analisi delle recidive - Terapi palliative in oncologia ginecologica 2000
- La terapia del carcinoma cervicale recidivante - Terapie palliative in oncologia ginecologica 2000
- Serum CA125 and other tumor markers in ovarian cancer - Diagnostic procedure and latest development in gynecologic and obstetric investigation. ESGOI 2001 2001
- La terapia ormonale sostitutiva in pazienti già trattate per neoplasia maligne della mammella o dell'apparato genitale femminile - Menopausa 2001 2001
- Second-line chemotherapy in recurrent ovarian cancer - ESGOI 2002. New technologies for gynecologic and obstetric investigation 2002
- Obesity and gynecologic cancer - ESGOI 2002. New technologies for gynecologic and obstetric investigation 2002
- Il carcinoma ovarico: diagnosi e terapia - Gli organi in ginecologia. Fisiopatologia, clinica e terapia: l'ovaio 2002
- Chemoprevention and endocrine therapy for endometrial carcinoma - Hormone replacement therapy and cancer. The current status of research and practice 2002
- Cutaneousmalignant melanoma; epidemiology, endocrine features and hormone replacement therapy - Hormone replacement therapy and cancer. The current status of research and practice 2002
- Chemoprevention and endocrine therapy forendometrial carcinoma - Hormone replacement therapy and cancer. The current status of research and practice 2002
- Cutaneous malignant melanoma : epidemiology, endocrine features and hormone replacement therapy - Hormone replacement therapy and cancer. The current status of research and practice 2002
- Uterine papillary serous carcinoma - Endometrial cancer 2003
- Il carcinoma endometriale. Inquadramento diagnostico e pianificazione terapeutica - Gli organi in ginecologia. Fiopatologia, clinica e terapia: l'Utero 2003
- Il sarcoma dell'utero: inquadramento diagnostico e pianificazione terapeutica - Gli organi in ginecologia. Fisiopatologia, clinica e terapia 2003
- Melanoma: risks of non-reproductive cancer and relationship to hormone replacement therapy - Menopause. The state of the art in research and management 2003
- Gynecologic malignancies and reproductive outcome - Pediatric and adolescent gynecology 2003
- I tumori ginecologici ormono-secernenti ed ormono-dipendenti - Endocrinologia ginecologica 2004
- Sarcomi dei tessuti molli, sarcomi dell'utero e capacità riproduttiva. - Neoplasie e fertilità 2005
- Reproductive Oncology - Breast cancer in pregnancy: a real clinical challenge 2007
- Aggiornamenti in senologia - Carcinoma mammario e gravidanza 2008
- Nephrotoxicity due to carboplatin therapy in ovarian cancer patients - Nephrotoxicity due to carboplatin therapy in ovarian cancer patients 2008
- Bollettino Ginecologia Endocrinologica - Il trattamento ormonale conservativo nelle pazienti giovani con iperplasia atipica o carcinoma endometriale 2009
- Libri, Manuali o Trattati
- Prodotti multimediali o Ideatori di prodotti multimediali